Mrs. Ann Maire Kaufmann, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 56 Glenn Dr, White Heath, IL 61884 Phone: 217-687-4902 |
News Archive
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute and breakthrough pain, today announced the initiation of an open-label Phase 3 study (SAP302) of ARX-04 for the treatment of adult patients who present in the emergency room with moderate-to-severe acute pain associated with trauma or injury.
My wife and I attended my 30-year college reunion a couple of weekends ago, but the partying was bittersweet. My freshman roommate, Scott Androes, was in a Seattle hospital bed, a victim in part of a broken health care system. Strip away the sound and fury of campaign ads and rival spinmeisters, and what's at stake in this presidential election is, in part, lives like Scott's. ... Scott now, at age 52, is suffering from Stage 4 prostate cancer, in part because he didn't have health insurance.
A new procedure can now treat esophageal perforations (holes in the esophagus) when caught early, therefore greatly reducing mortality rates.
Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.
iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announces a series of educational events designed for radiologists, urologists, oncologists, radiation oncologists, surgeons, technologists and other referring physicians who diagnose and treat patients with prostate cancer.
› Verified 5 days ago